{"cdcTestId":"2013-0467","testcaseName":"# 2 at age 26 yrs 11 months 15 days; forecast # 3; female","vaccineGroup":"HPV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1995-11-04T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2020-11-04T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2023-01-11T00:00:00","recommendedDate":"2023-02-19T00:00:00","pastDueDate":"2023-04-15T00:00:00"},"doses":[{"dateAdministered":"2020-11-04T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2022-03-01T07:47:55.205","generalDescription":"This test case describes when a patient is administered the second dose of the HPV vaccine after age 26 years that a third dose should be forecast.","changedInVersion":"4.21","reasonForChange":"v4.21: Updated test case to forecast a third dose.\nV4.2: Updated test case to remove forecast dose for the third dose of HPV because patient will have reached age 27 before administration of the dose based on newly published MMWR for Shared Clinical Decision Making starting at 27 years.\nV4.0: Updated recommended and past due to reflect general best practice recommendations timing and spacing table 3-1 (Rec. Date in 4 months)"}